TARDBP and amyotrophic lateral sclerosis: Kato et al. demonstrated that STAT3 inhibitors (such as niclosamide) can prevent TDP-43 mislocation and degradation, and reduce morphological changes, which suggested niclosamide as a therapeutic candidate for ALS [115].